Australia Markets closed

Avita Medical Limited (AVH.AX)


ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0770.00 (0.00%)
At close: 3:51PM AEST
Full screen
Previous close0.077
Open0.077
Bid0.076 x
Ask0.084 x
Day's range0.077 - 0.077
52-week range0.074 - 0.145
Volume198,000
Avg. volume612,057
Market cap52.44M
Beta0.67
PE ratio (TTM)-5.13
EPS (TTM)-0.01
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est0.27
  • Business Wire3 days ago

    New Randomized Trial Shows ReCell® Heals Donor Sites Faster

    VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England--(BUSINESSWIRE)-- Deploying a suspension of cells generated from a ReCell® medical device onto a skin donor site can speed up healing by 30.7% and deliver a superior final outcome, according to the results of a randomized controlled trial involving 106 patients who received skin grafts, Avita Medical (ASX:AVH.AX - News) (OTCQX:AVMXY - News), said today. Avita, a regenerative medicine company focused on the treatment of wounds and skin defects, said the findings reported in the British Journal of Surgery (BJS) further supported its growing data package around its ReCell® autologous cell harvesting device. This is the 3rd randomized controlled trial announced in recent weeks: last month, the Company presented data from two trials conducted at leading burns centers across the US, including successful results from its pivotal trial needed for PMA approval with the Food and Drug Administration.

  • Business Wire21 days ago

    Dr Michael S. Perry Appointed Avita Medical CEO

    VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England--(BUSINESSWIRE)-- The board of pioneering regenerative medicine company Avita Medical Limited (ASX: AVH ; OTCQX: AVMXY ) has appointed Dr Michael ...

  • Business Wirelast month

    Avita Medical’s Board Show Confidence in Company by Taking Payment in Shares

    NORTHRIDGE, Calif. & PERTH, Australia & CAMBRIDGE, England--(BUSINESSWIRE)-- The board of pioneering regenerative medicine company Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY), have shown a strong vote of confidence in the company by taking part or all of their Director’s fees in the form of shares. The Board policy of Avita is that individual Directors will invest an amount equivalent to 100% of their annual remuneration over a 3-4 year period. This policy follows from the shareholder approval of the employee share plan in November last year.